Hazel M Aker's Net Worth
$389 Thousand
Who is Hazel M Aker?
Hazel M Aker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Oncternal Therapeutics, Inc., CANCERVAX CORP, and CADENCE PHARMACEUTICALS INC.
SEC CIK
Hazel M Aker's CIK is 0001265783
Past Insider Trading and Trends
2005 was Hazel M Aker's most active year for acquiring shares with 6 total transactions. Hazel M Aker's most active month to acquire stocks was the month of February. 2019 was Hazel M Aker's most active year for disposing of shares, totalling 1 transactions. Hazel M Aker's most active month to dispose stocks was the month of February. 2020 saw Hazel M Aker paying a total of $149,997.44 for 96,198 shares, this is the most they've acquired in one year. In 2019 Hazel M Aker cashed out on 150,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Oncternal Therapeutics, Inc. (ONCT) Snapshot price: $9.6
Legal Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
| +836.93% | 41.97K |
$2.38 | $99,998.29 | 46.99K |
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
∞
| 9.3K |
—
|
—
| 9.3K |
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CANCERVAX CORP No price found
Sr. VP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 4
| +26.46% | 13.58K |
—
|
—
| 64.9K |
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
∞
| 11.25K |
—
|
—
| 11.25K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| +0.75% | 300 |
$12.00 | $3,600.00 | 40.07K |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CADENCE PHARMACEUTICALS INC No price found
SVP, GC & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||